$7.58
Today
as of Sep 4, 16:56 ET
Last 30 days
Recent Press Releases & News
Exagen (XGN) Q2 2026 Earnings Call Transcript
Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution
B. Riley Adjusts Price Target on Exagen to $12 From $8, Maintains Buy Rating
Overview
52-week range
$2.59
$12
52% of range
Avg surprise (last 3)
+9.7%
Avg reaction (last 2)
+19.4%
100% positive
Latest IV / EM
228%
EM ±35.6% · $8 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.13 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.17 | $-0.24 | +29.2% | +15.0% | +34.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.31 | — | — | — | — | financials |
| Tue Jul 29, 2025 | Jun/2025 | $-0.18 | $-0.18 | 0.0% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $-0.20 | $-0.20 | 0.0% | — | +3.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.28 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.16 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.19 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.31 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.28 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.44 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $17M | — | $17M | $17M | $15M | — | $13M |
| Cost of revenue | $8M | $7M | — | $7M | $7M | $6M | — | $6M |
| Gross profit | $12M | $10M | — | $10M | $10M | $9M | — | $7M |
| Operating income | $-2M | $-3M | — | $-3M | $-3M | $-3M | — | $-5M |
| Net income | $-3M | $-4M | — | $-7M | $-4M | $-4M | — | $-5M |
| EPS (diluted) | $-0.13 | $-0.17 | — | $-0.31 | $-0.21 | $-0.20 | — | $-0.28 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $25M | $22M | $32M | $36M | $30M | $11M | $22M | $22M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $43M | $44M | $49M | $53M | $51M | $33M | $36M | $36M |
| Total assets | $52M | $52M | $58M | $63M | $59M | $40M | $45M | $44M |
| Long-term debt | $22M | $22M | $22M | $22M | $22M | $18M | $20M | $20M |
| Total liabilities | $40M | $38M | $41M | $45M | $38M | $34M | $35M | $31M |
| Total equity | $12M | $14M | $17M | $18M | $21M | $6M | $10M | $13M |